feed,title,long_url,short_url
Barron's,uniQure Stock Is Higher After Investigators Conclude Its Gene Therapy Treatment Was Unlikely to Have Caused a Patient's Cancer,https://www.barrons.com/articles/uniqure-stock-is-higher-after-investigators-conclude-its-gene-therapy-treatment-was-unlikely-to-have-caused-a-patients-cancer-51617044753?mod=RTA,https://j.mp/3rBzLka
